Literature DB >> 19509547

Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer.

Animesh Barua1, Pincas Bitterman, Jacques S Abramowicz, Angela L Dirks, Janice M Bahr, Dale B Hales, Michael J Bradaric, Seby L Edassery, Jacob Rotmensch, Judith L Luborsky.   

Abstract

The high mortality rate due to ovarian cancer (OVCA) is attributed to the lack of an effective early detection method. Because of the nonspecificity of symptoms at early stage, most of the OVCA cases are detected at late stages. This makes the access to women with early-stage disease problematic and presents a barrier to development and validation of tests for detection of early stage of OVCA in humans. Animal models are used to elucidate disease etiologies and pathogenesis that are difficult to study in humans. Laying hen is the only available animal that develops OVCA spontaneously; however, detailed information on ovarian tumor histology is not available. The goal of this study was to determine the histological features of malignant ovarian tumors in laying hens. A total of 155 young and old (1-5 years of age) laying hens (Gallus domesticus) were selected randomly and evaluated grossly and microscopically for the presence of ovarian tumors. Histological classification of tumors with their stages and grades was determined with reference to those for humans. Similar to humans, all 4 types including serous, endometrioid, mucinous, and clear cell or mixed carcinomas were observed in hen ovarian tumors. Some early neoplastic as well as putative ovarian lesions were also observed. Similarities in histology, metastasis, and stages of hen OVCA to those of humans demonstrate the feasibility of the hen model for additional delineation of the mechanism underlying ovarian carcinogenesis, preclinical testing of new agents for the prevention, and therapy of this disease.

Entities:  

Mesh:

Year:  2009        PMID: 19509547      PMCID: PMC2759668          DOI: 10.1111/IGC.0b013e3181a41613

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  29 in total

Review 1.  Early detection of ovarian cancer: promise and reality.

Authors:  Robert C Bast; Nicole Urban; Viji Shridhar; David Smith; Zhen Zhang; Steven Skates; Karen Lu; Jinsong Liu; David Fishman; Gordon Mills
Journal:  Cancer Treat Res       Date:  2002

Review 2.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

3.  Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies.

Authors:  Roberta B Ness; Daniel W Cramer; Marc T Goodman; Susanne Krûger Kjaer; Kathy Mallin; Berit Jul Mosgaard; David M Purdie; Harvey A Risch; Ronald Vergona; Anna H Wu
Journal:  Am J Epidemiol       Date:  2002-02-01       Impact factor: 4.897

4.  A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis.

Authors:  Mack N Barnes; Wallace D Berry; J Michael J Straughn; Tyler O Kirby; Charles A Leath; Warner K Huh; William E Grizzle; Edward E Partridge
Journal:  Gynecol Oncol       Date:  2002-10       Impact factor: 5.482

5.  Descriptive epidemiology of ovarian cancer in the United States, 1992-1997.

Authors:  Marc T Goodman; Holly L Howe
Journal:  Cancer       Date:  2003-05-15       Impact factor: 6.860

6.  Stage at diagnosis of ovarian cancer in the United States, 1992-1997.

Authors:  Marc T Goodman; Catherine N Correa; Ko-Hui Tung; Steven D Roffers; Xiao Cheng Wu; John L Young; Lynne R Wilkens; Michael E Carney; Holly L Howe
Journal:  Cancer       Date:  2003-05-15       Impact factor: 6.860

Review 7.  Rodent models for ovarian cancer research.

Authors:  K D Sloan Stakleff; V E Von Gruenigen
Journal:  Int J Gynecol Cancer       Date:  2003 Jul-Aug       Impact factor: 3.437

Review 8.  Epidemiological and molecular aspects of ovarian cancer risk.

Authors:  I B Runnebaum; E Stickeler
Journal:  J Cancer Res Clin Oncol       Date:  2001-02       Impact factor: 4.553

Review 9.  Ovarian cancer: epidemiology, biology, and prognostic factors.

Authors:  C H Holschneider; J S Berek
Journal:  Semin Surg Oncol       Date:  2000 Jul-Aug

Review 10.  Animal models of ovarian cancer.

Authors:  Barbara C Vanderhyden; Tanya J Shaw; Jean-François Ethier
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

View more
  66 in total

Review 1.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

Review 2.  Precursors of ovarian cancer in the fallopian tube: serous tubal intraepithelial carcinoma--an update.

Authors:  Felix Zeppernick; Ivo Meinhold-Heerlein; Ie-Ming Shih
Journal:  J Obstet Gynaecol Res       Date:  2014-10-20       Impact factor: 1.730

Review 3.  Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.

Authors:  Anthony N Karnezis; Kathleen R Cho
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

4.  Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.

Authors:  Sergio A Machado; Janice M Bahr; D Buck Hales; Andrea G Braundmeier; Bradley J Quade; Romana A Nowak
Journal:  Biol Reprod       Date:  2012-10-11       Impact factor: 4.285

5.  Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner.

Authors:  Anushka Dikshit; Manoel Adrião Gomes Filho; Erfan Eilati; Stacey McGee; Carrie Small; Chunqi Gao; Thomas Klug; Dale Buchanan Hales
Journal:  Br J Nutr       Date:  2015-04-08       Impact factor: 3.718

6.  Dicer1, AGO3, and AGO4 microRNA machinery genes are differentially expressed in developing female reproductive organs and overexpressed in cancerous ovaries of chickens.

Authors:  W Jeong; H Bae; W Lim; G Song
Journal:  J Anim Sci       Date:  2017-11       Impact factor: 3.159

Review 7.  Minireview: animal models and mechanisms of ovarian cancer development.

Authors:  Lisa K Mullany; JoAnne S Richards
Journal:  Endocrinology       Date:  2012-03-06       Impact factor: 4.736

8.  Gene expression profiling reveals differentially expressed genes in ovarian cancer of the hen: support for oviductal origin?

Authors:  Lindsey S Treviño; James R Giles; Wei Wang; Mary Ellen Urick; Patricia Ann Johnson
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

9.  The hen as a model of ovarian cancer.

Authors:  Patricia A Johnson; James R Giles
Journal:  Nat Rev Cancer       Date:  2013-05-16       Impact factor: 60.716

10.  Long term consumption of flaxseed enriched diet decreased ovarian cancer incidence and prostaglandin E₂in hens.

Authors:  Erfan Eilati; Janice M Bahr; Dale Buchanan Hales
Journal:  Gynecol Oncol       Date:  2013-05-23       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.